The European Union is to amend current levels of red yeast rice-derived monacolins permitted in food in a move that ends the regulatory wrangling of this component dating back to 2010.
The European Commission (EC) moves to decrease the maximum limit of mycotoxin contaminant deemed acceptable for supplements fermented with red yeast rice.
Industry should fight amendments to a Belgian decree setting out minimum and maximum levels for caffeine, lutein, lycopene and red yeast rice, because some proposed levels fall well below established EFSA safety data, an expert claims.
Fresh safety warnings from the Belgian and German authorities highlight the need for member state compromise on the classification of monacolin K from red yeast rice, a consumer group says.
Different maximum limits for red yeast rice mean the natural cholesterol management product is a food supplement in one country but a drug in others. Is it time for EU harmonisation?
The French food agency (ANSES) has issued a warning against EU-backed cholesterol-managing nutrient red yeast rice after last year raising a red flag due to 25 illness since 2009.
The French food safety agency (ANSES) has called for input into the safety of red yeast rice – commonly used in food supplements with EFSA-backed cholesterol management health claims – after it was made aware of 25 adverse events.
A daily dose of red yeast rice safely reduces elevated cholesterol levels, decreases a marker of inflammation, and lowers markers of vascular remodeling, says a new study from Italy that further supports the safety and efficacy of the supplement.
A French firm has won a rare EFSA approval for an artichoke extract-based herbal formulation the EU’s central science agency has confirmed can reduce cholesterol.
French supplier Sylvan Bio is seeking dialogue with the European Food Safety Authority (EFSA) and EU authorities after the agency said in a just-issued positive article 13.5 health claim opinion there was no difference between Sylvan’s red yeast rice...
UK supplier Gee Lawson has debuted organic red yeast rice (Monascus purpureus) into a sector dominated by Chinese supply and which has won a European Union health claim for cholesterol maintenance.
Daily supplements containing red yeast rice, policosanols and artichoke leaf extracts may reduce cholesterol levels by 14%, according to data from a human trial.
A beverage containing red yeast rice may reduce LDL cholesterol levels by 18%, and offer a blood lipid lowering alternative for people intolerant to statins, says a new study.
European health claim experts say the devil may be in the detail of two positive European Food Safety Authority (EFSA) health claim opinions for red yeast rice and creatine that featured in the final batch of article 13, general function claims issued...
Commercially available formulations of red yeast rice are extremely variable in the concentration of active ingredients they contain, according to a report published in the Archives of Internal Medicine.
Dietary supplements of red yeast rice may lower LDL cholesterol levels by 21 per cent, and offer a blood lipid lowering alternative for people intolerant to statins, says a new study.
American researchers have found red yeast rice to be effective in treating hyperlipidemia – the elevation of potentially damaging lipids in the blood – but who cannot tolerate statin treatment.
A US product survey has found that four out of ten red yeast rice
supplements were contaminated with a fungal substance called
citrinin that has been linked with kidney problems in animal and
human populations.
OsteoScreen, a Texas-based bone screening laboratory, has been
awarded a patent for the use of red yeast rice as an ingredient in
its OsteoPure bone-building supplement.
